Maximize Safety and Minimize Risk: HPAPI Discovery to Manufacturing

The HPAPI Development & Manufacturing Summit 2014 agenda has now been finalised and is available to download here.

The 28–29 May meeting in Boston, USA, organised by Hanson Wade, will bring together the HPAPI community to discuss practical insights and best practices that will provide you with the tools to build your strategy for commercial HPAPI manufacturing success:

• Align banding standards to achieve industry consistent definitions

• Discover the latest containment technologies that can advance your potent molecule handling capabilities

• Enhance your safety measures and ensure worker protection

• Scale up your manufacturing to optimize your products' potential in the market

Hear from the experts in high potent compound development, handling and manufacturing such as

• Patricia Weideman, Director, Product Quality & Occupational Toxicology, Genentech

• Clark Richards, Senior Process Engineer, Abbvie

• Greg Baker, Associate Director, EH&S and Enterprise Risk Management, Eisai

• Robert Sussman, Managing Principal, Eastern Operations, SafeBridge Consultants Inc

• Paul Richards, Senior Process Engineer, Biogen Idec

• And many more...

Download the brochure to view the full speaker faculty and agenda

Learn and share experiences with leaders in the field through presentations, interactive panel discussions, group round table discussions and short fire talks that will deliver industry-defining information that you can implement into your business strategy.